Insulin
No structure available
Insulin could not be matched to a single known compound.
Background
Listing
- Schedules
- Schedule 3
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
3 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Insulin human | Insuman rapid ( ), Insuman basal ( ), Insuman comb ( ) | 300 IU/3 ML, 300 IU/3 ml 30/70, 1000 IU/10 ML, 1000 IU/10 ML 30/70 | Sanofi-aventis South Africa (Pty) Ltd | 6 registrations | S3 |
| Insulin | Apidra, Actrapid hm (ge) | 1 mL, 100 units | 2 applicants | 2 registrations | S3 |
| Insulin zinc Cancelled | Isophane insulin, Insulin (lente) | Not stated | The Boots Company (SA) (Pty) Ltd | 2 registrations | S3 |
9 more registered products name Insulin in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Insulin lispro | Humalog, Humalog mix, Humalog kwikpen, +8 more | 25, 50, 100 units/ml, 200 units/ml | 2 applicants | 12 registrations | S3 |
| Insulin aspart | Novorapid, Novomix, Fiasp, +1 more | 100 U/mL | 2 applicants | 4 registrations | S3 |
| Insulin glargine | Lantus, Optisulin, Basaglar, +5 more | 000 IU/10 ml 1, 3.64mg / 1ml, 100 IU/mL, 500 IU/5 ml | 4 applicants | 10 registrations | S3 |
| Insulin detemir | Levemir | Not stated | Novo Nordisk (Pty) Ltd û (Rivonia) | 380084 | |
| Insulin glulisine Cancelled | Gluliwin | Not stated | Sanofi-aventis South Africa (Pty) Ltd | 410349 | |
| Insulin degludec | Tresiba | 100 U/ml, 200 U/ml | Novo Nordisk (Pty) Ltd û (Rivonia) | 2 registrations | S3 |
| Insulin aspart, insulin degludec | Ryzodeg | Not stated | Novo Nordisk (Pty) Ltd û (Rivonia) | 470165 | S3 |
| Insulin degludec, liraglutide Cancelled | Xultophy | Not stated | Novo Nordisk (Pty) Ltd û (Rivonia) | 500985 | S3 to S4 |
| Insulin glargine, lixisenatide | Soliqua, Vivsuna | 33/100, 50/100 | Sanofi-aventis South Africa (Pty) Ltd | 4 registrations | S3 to S4 |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Insulin
S3: Insulin
Consolidated Schedules 06 July 2026, line 3794
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.